Edition:
India

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

1.18USD
23 Aug 2019
Change (% chg)

$-0.06 (-4.84%)
Prev Close
$1.24
Open
$1.22
Day's High
$1.22
Day's Low
$1.15
Volume
3,182
Avg. Vol
4,189
52-wk High
$2.86
52-wk Low
$0.91

Latest Key Developments (Source: Significant Developments)

BIOLASE Reports Q2 Loss Per Share $0.18
Friday, 9 Aug 2019 

Aug 8 (Reuters) - BIOLASE Inc ::BIOLASE REPORTS SECOND QUARTER 2019 RESULTS.Q2 NON-GAAP LOSS PER SHARE $0.13.Q2 LOSS PER SHARE $0.18.Q2 REVENUE FELL 29 PERCENT TO $8.7 MILLION.Q2 REVENUE ESTIMATE $12.6 MILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE ESTIMATE $-0.12 -- REFINITIV IBES DATA.CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TOTALED $4.0 MILLION AS OF JUNE 30, 2019.  Full Article

Archon Capital Management Reports A Passive Stake Of 7.66% In Biolase As Of June 25, 2019
Friday, 5 Jul 2019 

July 5 (Reuters) - BIOLASE Inc ::ARCHON CAPITAL MANAGEMENT REPORTS A PASSIVE STAKE OF 7.66% IN BIOLASE AS OF JUNE 25, 2019.  Full Article

Biolase Posts Q1 Loss Per Share Of $0.23
Friday, 10 May 2019 

May 9 (Reuters) - BIOLASE Inc ::BIOLASE REPORTS FIRST QUARTER 2019 RESULTS.Q1 NON-GAAP LOSS PER SHARE $0.15.Q1 LOSS PER SHARE $0.23.Q1 REVENUE $10.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $10.4 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.18 -- REFINITIV IBES DATA.  Full Article

Biolase Reports Q4 Loss Per Share $0.05
Thursday, 15 Mar 2018 

March 14 (Reuters) - Biolase Inc ::BIOLASE REPORTS 2017 FOURTH QUARTER AND FULL-YEAR RESULTS.Q4 NON-GAAP LOSS PER SHARE $0.04.Q4 REVENUE FELL 8 PERCENT TO $12.6 MILLION.Q4 LOSS PER SHARE $0.05.  Full Article

Biolase Announces MoU With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Deviceinnovative Clearview Scan Device
Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Biolase Inc ::BIOLASE INC - ANNOUNCES MOU WITH S-RAY TO MARKET, SELL DISRUPTIVE RADIATION-FREE DENTAL IMAGING DEVICEINNOVATIVE CLEARVIEW SCAN DEVICE.  Full Article

CAO Group Filed Patent Infringement Lawsuits In Court Against Biolase
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - CAO GROUP INC:CAO GROUP INC- FILED PATENT INFRINGEMENT LAWSUITS IN UNITED STATES DISTRICT COURT AGAINST BIOLASE INC.  Full Article

Biolase Files For Possible Resale Of Up To 21.9 Mln Shares Of Common Stock By Selling Stockholders
Wednesday, 17 Jan 2018 

Jan 16 (Reuters) - Biolase Inc ::BIOLASE INC FILES FOR POSSIBLE RESALE OF UP TO 21.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Biolase reports Q3 non-GAAP loss per share $0.05
Thursday, 2 Nov 2017 

Nov 1 (Reuters) - Biolase Inc :Biolase reports 2017 third quarter and nine-month results.Q3 non-GAAP loss per share $0.05.Q3 loss per share $0.06.Q3 revenue rose 18 percent to $10.8 million.  Full Article

Biolase appoints Richard Lanman to board of directors
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Biolase Inc ::Biolase appoints Richard B. Lanman to board of directors.Biolase - ‍Lanman replaces outgoing director Fredrick Moll​.  Full Article

BIOLASE names Jonathan T. Lord chairman of the board
Tuesday, 5 Sep 2017 

Sept 5 (Reuters) - Biolase Inc :BIOLASE Inc - ‍announced that on September 1, named Jonathan T. Lord, as its new chairman of board​.BIOLASE Inc - ‍Lord replaces outgoing chairman Paul N. Clark​.  Full Article